Ritesh Kotecha
@KotechaMD
Followers
182
Following
16
Statuses
14
GU MED Onc @sloan_kettering, focused in #kidneycancer, @BIDMC_IM alum, views=own
Manhattan, NY
Joined February 2020
RT @MSK_DeptOfMed: New research from @MSKCancerCenter takes a step toward off-the-shelf CAR T cell therapy for #cancer. Author Karlo Perica…
0
14
0
RT @yasserged: Our paper on IO combinations in metastatic translocation RCC is now online. Great collaborative work and addition to treatme…
0
13
0
RT @UrolOncol: Gene expression of prostate-specific membrane antigen (FOLH1) in clear cell renal cell carcinoma predicts angiogenesis and r…
0
3
0
RT @EdReznik: A new article from our group with @KotechaMD and led by Lennert Eismann + Amy Xie reports that investigational RNA biomarkers…
0
6
0
RT @MiamiCancerInst: 📣Dr. Rupesh Kotecha, chief of radiosurgery, has been invited to present with the Middle Eastern Society for Stereotact…
0
1
0
RT @BrendanGuercio: Thank you @KidneyCancer for this tremendous & humbling opportunity to help advance the field of research for patients a…
0
3
0
RT @OncHahn: (1/n) Our latest work in @EurUrolFocus is a retrospective study from @MSKCancerCenter and @MDAndersonN…
0
27
0
RT @urotoday: Genetic ancestry and molecular correlations in patients with #KidneyCancer. Presentation by @KotechaMD @MSKCancerCenter. #IKC…
0
2
0
RT @EUplatinum: Progression-free Survival After Second Line of Therapy for Metastatic Clear Cell Renal Cell Carcinoma in Patients Treated w…
0
14
0
RT @SGreenbergGC: Last #KCRS22 tweet: @KotechaMD and I went to @MidlandPS ‘s Dow High years ago. Now, as a GU #geneticcounselor and #oncolo…
0
1
0
RT @EdReznik: New work on SDH-/FH-deficient RCC from our @MSKCancerCenter Kidney Cancer Team, driven by (newly matched!) med student Angela…
0
3
0
RT @lsalas_epigenet: We are part of this outstanding Academy of Kidney Cancer Investigators @BraunMDPhD @AChakrabortyPhD @KotechaMD Amrita…
0
5
0